|
|
|
|
Vol. 301, Issue 2, 501-506, May 2002
Department of Pharmacology, University of Connecticut Health Center, Farmington, Connecticut
| |
Abstract |
|---|
|
|
|---|
Does cGMP, via protein kinase G, inhibit cAMP-stimulated
Ca2+ current (ICa(L)) in mammalian ventricular
myocytes by phosphorylating the calcium channel at a site
different from that acted on by cAMP or by dephosphorylating the
calcium channel through phosphatase(s)? We tested these possibilities
in guinea pig ventricular myocytes superfused with Tyrode's solution
(35°C) and dialyzed with adenosine 5'-O-(3-thiotriphosphate) ([ATP
S]pip).
ATP
S is a kinase substrate but thiophosphorylated proteins are not
phosphatase substrates. With 5 mM [ATP
S]pip,
ICa(L) increased gradually over 20 to 25 min and then
rapidly in the presence of 3-isobutyl-1-methylxanthine. 8-Bromo-cGMP
(8-Br-cGMP; 1 mM) did not inhibit ICa(L) significantly (
3 ± 11.8%, n = 21) in contrast to results
with ATP dialysis (Imai et al., 2001
). Similar results were obtained
with 0.1 mM carbachol (CCh). ICa(L) increased after longer
dialysis (
40 min) with ATP
S; again, 8-Br-cGMP had no effect. Also,
isoproterenol (ISO) did not stimulate and CCh, alone or in the presence
of ISO, did not inhibit ICa(L). Block of CCh effect by
ATP
S, although consistent with cGMP action in muscarinic
inhibition, could be explained by guanosine
5'-O-(3-thiotriphosphate) (GTP
S) formation from
ATP
S via nucleoside diphosphate kinase. GTP
S uncouples muscarinic
and
-adrenoceptors from intracellular effectors. Failure of
8-Br-cGMP to reduce ICa(L) irreversibly excludes calcium
channel phosphorylation as an inhibitory mechanism. We propose that
cGMP inhibits ICa(L) by activating phosphatase(s) in guinea
pig ventricular myocytes.
| |
Introduction |
|---|
|
|
|---|
Extrinsic
regulation of heart function usually involves opposing actions by the
autonomic nervous system. The yin-yang hypothesis placed the
postjunctional actions in the context of intracellular messengers, cAMP
and cGMP, and their respective protein kinases having opposite effects
on cellular processes (Watanabe and Besch, 1975
). One target, the
L-type calcium channel, has received considerable attention because the
cAMP-activated protein kinase (PKA) increases current
(ICa(L)) through the channel whereas the
cGMP-activated kinase (PKG) decreases it (reviewed in McDonald et al.,
1994
).
In mammalian ventricle, cGMP-inhibited phosphodiesterase (PDE)
and PKG appear to be the principal effectors of cGMP with the former
causing ICa(L) to increase as it allows cAMP to
accumulate (Ono and Trautwein, 1991
; Shirayama and Pappano, 1996
).
Activation of PKG, in the presence of elevated cAMP, inhibits the
L-type calcium current but the proposed mechanisms differ. In rat
ventricular myocytes, inhibition of ICa(L) by
cGMP was ascribed to phosphorylation by PKG of the L-type calcium
channel or an associated regulatory protein (Méry et al., 1991
;
Sumii and Sperelakis, 1995
). When the
1c
subunit of the cardiac calcium channel is expressed in oocytes,
8-bromo-cGMP (8-Br-cGMP) inhibited basal current (Jiang et al., 2000
).
The PKG inhibitor KT5823 or replacement of serine by alanine at
a consensus site (S533A) for PKG-dependent phosphorylation prevented
inhibition by cGMP. In the
1c component of the
L-type channel, PKA phosphorylates a serine residue 1928 (Gao et al., 1997
). Thus, antagonistic modulation of ICa(L) by
cyclic nucleotides could be referable to phosphorylation of different
regulatory sites on the
1c subunit.
Activation of a phosphatase was excluded as a mechanism for
inhibition by cGMP/PKG (Méry et al., 1991
; Sumii and Sperelakis, 1995
). This conclusion is at odds with the observation that
acetylcholine (ACh), which increases cGMP, opposed PKA-dependent
phosphorylation of proteins in guinea pig ventricular myocytes (Gupta
et al., 1994
). This was attributed to activation of protein phosphatase (PP). Okadaic acid, an inhibitor of PP, prevented dephosphorylation of
proteins (Gupta et al., 1994
) and inhibition of isoproterenol (ISO)-stimulated ICa(L) by ACh (Herzig et al.,
1995
). The phosphatase hypothesis was strengthened by evidence that
inhibition of ICa(L) by carbachol (CCh) or
8-Br-cGMP was antagonized by dialysis with 300 nM okadaic acid (Sakai
et al., 1999
). As such, the results resemble those seen in
GH4C1 cells where atrial
natriuretic peptide increased a maxi-K channel current by activating a
phosphatase through a cGMP/PKG pathway (White et al., 1993
). Okadaic
acid prevented maxi-K current stimulation by atrial natriuretic
peptide. When Ba2+ current through
1c subunits expressed in human embryonic
kidney cells is elevated by forskolin-induced activation of adenylyl cyclase, phosphatase inhibition by okadaic acid potentiates this current and the phosphorylation of serine 1928 (Gao et al., 1997
).
We evaluated the phosphatase activation hypothesis for cGMP
action on ICa(L). Our experiments were done with
ATP
S replacing ATP in the pipette solution
[ATP
S]pip; 8-Br-cGMP was used to activate
PKG. ATP
S is a kinase substrate; the thiophosphorylated substrate
resists phosphatase action (Yount, 1975
). With 3 mM [ATP
S]pip, ISO increased
ICa(L) more than with ATP and the stimulant effect persisted when ISO was removed (Kameyama et al., 1985
; Sipido et
al., 1995
). PKA and PKG phosphorylate the L-type calcium channel at
different sites. With ATP
S present, we assume that if the effect of
thiophosphorylation by PKA on ICa(L) cannot be reversed by activation of PKG, the antagonistic interaction in ATP
occurs by dephosphorylation of the site phosphorylated by cAMP/PKA. On
the other hand, if cGMP can oppose the effect of cAMP on
ICa(L) in the presence of ATP
S, the antagonism
most likely occurs by thiophosphorylation of a different regulatory
site on the
1c subunit.
| |
Materials and Methods |
|---|
|
|
|---|
Ventricular Myocyte Isolation.
Single ventricular myocytes
were isolated from the hearts of guinea pigs (250-450 g) anesthetized
with sodium pentobarbital (30 mg/kg, intraperitoneally) and
anticoagulated with heparin (1000 IU, i.p.). The heart was perfused
according to the Langendorff technique with modified Tyrode's solution
containing 135 mM NaCl , 5.4 mM KCl, 1.8 mM
CaCl2, 1.0 mM MgCl2, 0.33 mM NaH2PO4, 10 mM HEPES,
and 20 mM glucose (pH was 7.4 with NaOH). The procedures are the same
as we reported previously (Imai et al., 2001
). After collagenase and
protease disrupted the extracellular matrix, the enzymes were washed
out by perfusion with 50 ml of recovery solution containing 130 mM
potassium aspartate, 5 mM K2ATP, 5 mM HEPES, and
20 mM glucose; pH was adjusted to 7.4 with KOH. The ventricles were
removed, and the cells were dispersed in recovery solution and kept at
4°C for at least 1 h. A cell suspension droplet was placed in a
chamber (500-µl volume) on the stage of an inverted microscope. After
10 min, superfusion began with Tyrode's solution (2 ml/min) containing
10 mM glucose and 10 mM CsCl (35°C).
Electrophysiology.
The patch rupture-whole cell
voltage clamp technique used an EPC 7 patch-clamp amplifier (List
Electronics, Darmstadt, Germany). Voltage commands and data acquisition
were obtained with pClamp software (version 5.5; Axon Instruments,
Union City, CA) and a Labmaster TL-1 interface (Axon Instruments). The
pipette filling solution for glass electrodes (i.d.,1.1 mm; o.d.,1.3
mm) contained 135 to 140 mM cesium aspartate, 7 mM NaCl, 3.0 mM
MgCl2, 3.5 or 5 mM ATP
S, 10 mM EGTA, and 10 mM
HEPES; pH 7.3 (with CsOH). In some experiments, the pipette solution
also contained 1 mM GTP. The electrode resistance was 1 to 3 M
.
Series resistance could be compensated up to 70% to values between 1 and 2.5 M
.
80 to
40 mV for 300 ms to
inactivate the fast Na+ and T-type
Ca2+ currents. A second voltage step to +10 mV
for 300 ms elicited ICa(L). The clamp protocol
was repeated every 10 s.
Drugs and Application. Drugs were applied to myocytes by superfusion by gravity from a reservoir. The applied solutions were warmed to provide an experimental temperature of 35°C. CCh, ISO, 8-Br-cGMP, and 3-isobutyl-1-methylxanthine (IBMX) were prepared fresh daily from aqueous stock solutions.
Data Analysis.
With Cs+-rich
pipette solution to block membrane K+ currents,
ICa(L) is taken as peak current minus
end-of-pulse current at +10 mV. Measurements are reported as mean ± S.E.M. The statistical significance of mean differences was
determined by Student's t test. p
0.05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
8-Br-cGMP inhibits ICa(L) augmented by ISO
or IBMX. At 0.1 mM, 8-Br-cGMP inhibited ICa(L) in
0.1 mM IBMX by 34 ± 3.6% and in 10 nM ISO by 32 ± 7.1%
(Imai et al., 2001
). Accordingly, one would expect 0.1 mM 8-Br-cGMP to
suppress cAMP-stimulated ICa(L) by about
one-third. In the following experiments, a 10-fold greater concentration of 1 mM 8-Br-cGMP was used.
The results of a test with 8-Br-cGMP on IBMX-stimulated
ICa(L) are shown in Fig.
1. The L-channel current was
0.7 nA
upon patch rupture and gradually increased to
1.4 nA after 25 min, during which time the cell had been dialyzed with
[ATP
S]pip of 5 mM. In this experiment, the
pipette solution also contained 1 mM GTP. Addition of 0.1 mM IBMX to
the superfusion fluid markedly increased ICa(L)
to
4.6 nA at 30 min. When 1 mM 8-Br-cGMP was present for 5 min with
IBMX, ICa(L) remained at
4.6 nA. Washout of
8-Br-cGMP ensued and ICa(L) remained elevated at
4.6 nA up to 40 min. This result is characteristic of that observed
in a total of 21 cells in which 8-Br-cGMP was tested on cAMP-elevated ICa(L). In three of these cells, 10 nM ISO was
used to stimulate ICa(L), and the results are
included with those obtained with IBMX because the outcome was the
same. Overall, the initial ICa(L) just before
addition of cAMP-elevating agent was
1.0 ± 0.13 nA and it
increased to
2.6 ± 0.27 nA (n = 21). On
average, 1 mM 8-Br-cGMP changed cAMP-elevated
ICa(L) by
3 ± 11.8% (n = 21), which is not significantly different from 0. 8-Br-cGMP reduced ICa(L) by
16 ± 5.6% (n = 8) in cells dialyzed with ATP
S for <25 min, and by 5 ± 18.7%
(n = 13) in cells dialyzed for >25 min (p = 0.2). Importantly, if 8-Br-cGMP reduced
IBMX-stimulated ICa(L), the effect was transient.
|
There were two cells in which we did not observe this pattern; an
example is shown in Fig. 2. The L-channel
current increased from
1.4 to
2.8 nA during the first 10 min of
dialysis; the pipette solution was the same as for the cell in Fig. 1.
Addition of 0.1 mM IBMX at 10 min had a small stimulant effect on
ICa(L) that eventually reached
3 nA at 16 min.
When 1 mM 8-Br-cGMP was added, ICa(L) diminished
rapidly over the next 4 min to
0.4 nA. The current did not change
appreciably over the ensuing 15 min when 8-Br-cGMP and then IBMX were
washed out. This result resembles that reported by Méry et al.
(1991)
in which cGMP irreversibly reduced cAMP-stimulated
ICa(L). However, it is exceptional because it
occurred in only 2 of the 23 cells tested and cannot be distinguished from rundown. In both instances, IBMX had been added at about 10 min
after patch rupture and 8-Br-cGMP tested 5 min later. The time of IBMX
addition ranged from 6 to 28 min with an average of 16 ± 2 min in
the 21 cells where the effect of 8-Br-cGMP was suppressed.
|
Inhibition of ISO- or IBMX-stimulated ICa(L) by
CCh has been reported by many investigators. We found that 0.1 mM CCh
inhibited ISO-stimulated ICa(L) by 77 ± 7.9% and IBMX-stimulated ICa(L) by 79 ± 6.3% (Imai et al., 2001
). However, in cells dialyzed with ATP
S, CCh
had little effect when tested against IBMX-stimulated ICa(L). An example is shown in Fig.
3. In this cell,
ICa(L) was
0.2 nA upon patch rupture and
increased to
0.9 nA during the next 20 min as the cell was dialyzed
with [ATP
S]pip of 5 mM and [GTP]pip of 1 mM. Again, 0.1 mM IBMX, added at
20 min, promptly increased ICa(L) to
5 nA (Fig.
3). Current did not change upon addition of 0.1 mM CCh to the bath
fluid for 5 min. When CCh was removed from the IBMX-containing
solution, ICa(L) remained at
5 nA through 40 min.
|
Overall, 0.1 mM CCh reduced cAMP-elevated
ICa(L) by
32 ± 9.9% (n = 12). Although this is substantially less than that observed with ATP in
the pipette solution (see above), it is greater than the inhibition
observed with 8-Br-cGMP in separate experiments. However, when both
were tested in the same six cells against IBMX-stimulated ICa(L), CCh reduced current by
29 ± 13.3% (32 ± 5.2 min) and 8-Br-cGMP reduced it by
21 ± 9.7% (26 ± 7.1 min). In nine cells, we obtained stable
recordings during dialysis with [ATP
S]pip of
3.5 to 5 mM for
45 min. Under these conditions, tests with 1 mM
8-Br-cGMP (n = 5) or with 0.1 mM CCh (n = 7) revealed no inhibition of stimulated ICa(L)
by either ligand (data not shown).
| |
Discussion |
|---|
|
|
|---|
With PDEs inactivated by IBMX, we assume that there are two
pathways for inhibition of ICa(L) by cGMP/PKG,
namely, phosphorylation of the
1c subunit that
antagonizes the stimulant effect of cAMP/PKA and/or activation of PP
that dephosphorylates the
1c subunit. Can
8-Br-cGMP or CCh suppress Ca2+ current through
L-type channels in the presence of ATP
S, which allows kinases to
thiophosphorylate substrates that resist phosphatase action?
Irreversible suppression by 8-Br-cGMP would indicate that thiophosphorylation of the channel had occurred at a site different from that acted upon by cAMP/PKA (Méry et al., 1991
; Sumii and Sperelakis, 1995
). Alternatively, failure of 8-Br-cGMP to suppress ICa(L) in ATP
S would indicate that the
thiophosphorylated channel was resistant to phosphatase. Our results
are consistent with the PP hypothesis for inhibition by cGMP of current
through L-type channels in guinea pig ventricular myocytes.
Neurotransmitter regulation of ICa(L) by
reversible phosphorylation-dephosphorylation reactions is well known
(McDonald et al., 1994
; Herzig and Neumann, 2000
). Serine 1928 of the
1c subunit has been reported to be an
essential residue for phosphorylation by PKA (Gao et al., 1997
). Our
results point to the possibility that the site for phosphatase action
on the
1c subunit is the same. This conclusion
differs from that of others in several ways. Those who report that cGMP
irreversibly inhibits ICa(L) by phosphorylation of the channel did experiments in rat ventricular myocytes (Méry et al., 1991
; Sumii and Sperelakis, 1995
). A similar conclusion emerged
from experiments with mouse ventricular myocytes (Klein et al., 2000
).
We did not observe suppression of basal ICa(L) by
8-Br-cGMP unlike the results from rat ventricular myocytes (Sumii and
Sperelakis, 1995
). Our experiments and those reporting cGMP/PKG-induced
activation of PP are from guinea pig ventricular myocytes (reviewed in
Herzig and Neumann, 2000
). Different species have distinct regulatory
mechanisms for cGMP-dependent regulation of
ICa(L). In amphibian ventricular myocytes, cGMP
stimulated PDE, which reduces cAMP concentration (reviewed in
Méry et al., 1997
). This pathway is not prominent in mammalian
ventricular myocytes and would be inoperative in our experiments
because IBMX inhibits all PDEs. In human atrial trabeculae, 8-Br-cGMP
had a negative inotropic effect (Nawrath et al., 1995
; Flesch et al., 1997
) but increased ICa(L) in single myocytes
(Vandecasteele et al., 2001
). Stimulation of
ICa(L) by 8-Br-cGMP was attributed to activation
of PKA. Although PKG was excluded as an effector of 8-Br-cGMP in single
atrial myocytes (Vandecasteele et al., 2001
), it may have been the
target in experiments with human atrial trabecular contractions
(Nawrath et al., 1995
; Flesch et al., 1997
). No information is
available on effectors of 8-Br-cGMP in human ventricle, which
conceivably differ from those in atrium (Vandecasteele et al., 2001
).
8-Br-cGMP could sometimes inhibit ICa(L) in cells
dialyzed for
25 min with ATP
S. However, the inhibition was
reversible, a finding inconsistent with cGMP/PKG causing irreversible
inhibition via thiophosphorylation of the L-type calcium channel in rat
ventricular myocytes (Méry et al., 1991
). In only 2 of 23 cells,
8-Br-cGMP addition was accompanied by a sustained decrease of
ICa(L) (Fig. 2). Although this could be an
example of irreversible inhibition, it cannot be distinguished from
current rundown. Sufficient time should be allowed for diffusion of
ATP
S from the pipette solution and for replacing ATP for
participation in thiophosphorylation reactions including those at the
L-type calcium channel.
That ATP
S interfered with inhibition of ICa(L)
by 8-Br-cGMP favors the participation of PKG-activated PP in the cGMP
signaling pathway. Dialysis with either PP1 or PP2A opposed
ISO-stimulated ICa(L), but not basal
ICa(L), in guinea pig ventricular myocytes (Hescheler et al., 1987
). Okadaic acid inhibits PP1 and PP2A with the
latter being more sensitive (Herzig and Neumann, 2000
). Okadaic acid
(300 nM in pipette solution) prevented inhibition of
ICa(L) by 8-Br-cGMP (Sakai et al., 1999
). That
okadaic acid inhibits membrane bound PP1 and PP2A activities in guinea
pig ventricular myocytes (Neumann et al., 1993
) indicates that neither
enzyme can be excluded from participating in
ICa(L) inhibition. Single channel recordings
indicated that PP2A and PP1 dephosphorylate the L-type
Ca2+ channel at different sites (Ono and Fozzard,
1993
; Wiechen et al., 1995
). Together with the present results, the
data with okadaic acid favor activation of PP as a mechanism for
cGMP/PKG signaling (see also White et al., 1993
).
ATP
S Prevents Inhibition by Carbachol of
ICa(L).
The ability of CCh to inhibit
ICa(L) diminished in cells dialyzed with ATP
S.
This is in accordance with the evidence that muscarinic agonist
inhibits ICa(L) by activating okadaic
acid-sensitive PP (Herzig et al., 1995
) and that cGMP is the signal
molecule for this action (Imai et al., 2001
), presumably by
phosphorylating PP (Sakai et al., 1999
). Similarly, ACh opposed the
action of ISO or dibutyryl-cAMP on the inwardly rectifying
K+ current by activation of okadaic
acid-sensitive PP in guinea pig ventricular myocytes (Koumi et al.,
1995
).
S on the response to CCh may not be
limited to interference with cGMP-stimulated PP activity.
Thiophosphorylation of guanine nucleotides occurs when ATP
S is
present (Otero et al., 1988
S allows formation of GTP
S from GDP via nucleoside
diphosphate kinase, which is present in cardiac membranes
(Heidbüchel et al., 1992
S is slow in onset but
irreversible after about 20 min (Heidbüchel et al., 1990
S formed from ATP
S not only activates
IK(ACh) irreversibly but also uncouples
G-protein-coupled receptors from intracellular effectors (Breitwieser
and Szabo, 1985
S was associated with a partially reversible effect on
IK(ACh) activation (Heidbüchel et al.,
1992Limitations.
An alternative possibility is that cGMP/PKG not
only activates PP but also phosphorylates the
1c subunit in guinea pig ventricular myocytes.
That is, with ATP present, both reactions occur and contribute to
suppression of cAMP/PKA-activated ICa(L). What
happens in the presence of ATP
S? With PP activity blocked, the most
likely mechanism for inhibition is cGMP/PKG-induced thiophosphorylation of serine 533 on the
1c subunit. If this were
so, one would have to conclude that these regulatory sites are not
equal and that serine 1928 dominates because when thiophosphorylated by
cAMP/PKA, thiophosphorylation of serine 533 by cGMP/PKG is unable to
cause inhibition.
1c subunit as phosphorylation by cAMP/PKA,
namely, serine 1928. However, cAMP/PKA also phosphorylates the
2a subunit of the L-type
Ca2+ channel and this is suggested to regulate
current through the pore-forming
1c subunit
(Bünemann et al., 1999
1c subunit used in
the experiments was truncated and lacked serine 1928.
Conceivably, a membrane-delimited pathway could allow GTP
S,
generated from ATP
S, to activate the L-type channel via the
subunit of the stimulatory guanine nucleotide-binding protein, Gs (Yatani et al., 1987
1c subunit phosphorylated by cAMP/PKA.
| |
Footnotes |
|---|
Accepted for publication January 14, 2002.
Received for publication October 31, 2001.
This work was supported by U.S. Public Health Service Grant HL-13339.
Address correspondence to: Dr. Achilles J. Pappano, Department of Pharmacology, MC-6125, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030. E-mail: pappano{at}nso1.uchc.edu
| |
Abbreviations |
|---|
PKA, protein kinase A;
ICa(L), L-type calcium current;
ATP
S, adenosine
5'-O-(3-thiotriphosphate);
GTP
S, guanosine
5'-O-(3-thiotriphosphate);
CCh, carbachol;
IBMX, 3-isobutyl-1-methylxanthine;
ISO, isoproterenol;
PKG, protein kinase G;
PP, protein phosphatase;
ACh, acetylcholine;
PDE, phosphodiesterase;
8-Br-cGMP, 8-bromo-cGMP;
KT5823, (9S,10R)-2,3,9,10,11,12-hexahydro-10-methoxy-2,-9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-k]pyrrolo[3,4-i][1,6] benzodiazocine-10-carboxylic acid methyl ester.
| |
References |
|---|
|
|
|---|
-adrenergic receptors from ion channels by a guanine nucleotide analogue.
Nature (Lond)
317:
538-540[CrossRef][Medline].
2 subunit.
J Biol Chem
274:
33851-33854
-adrenergic regulation of the Ca channel in the guinea-pig heart.
Pfluegers Arch
405:
285-293[CrossRef][Medline].
-adrenergic effect on Ca2+ current in guinea-pig ventricular cells.
J Physiol (Lond)
443:
387-404
S in atrial cells.
Science (Wash DC)
242:
443-445This article has been cited by other articles:
![]() |
S.-k. Wei, A. M. Ruknudin, M. Shou, J. M. McCurley, S. U. Hanlon, E. Elgin, D. H. Schulze, and M. C.P. Haigney Muscarinic Modulation of the Sodium-Calcium Exchanger in Heart Failure Circulation, March 13, 2007; 115(10): 1225 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Yu, L.-H. Cao, and X.-L. Yang Modulation by Brain Natriuretic Peptide of GABA Receptors on Rat Retinal ON-Type Bipolar Cells J. Neurosci., January 11, 2006; 26(2): 696 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Su, P. M. Scholz, and H. R. Weiss Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes Experimental Biology and Medicine, April 1, 2005; 230(4): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiong, G. R. Ferrier, and S. E. Howlett Diminished Inotropic Response to Amrinone in Ventricular Myocytes from Myopathic Hamsters Is Linked to Depression of High-Gain Ca2+-Induced Ca2+ Release J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 761 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu and P. A. Hofmann Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: role for p38 MAPK Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H97 - H103. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||